• Home
        •  | 
        • Partners log-in
      • About Cupron
        • News & Events
        • In the media
        • Cupron Management
        • Regulation
        • FAQ
        • Contact
      • Markets
        • Consumer
        • Industrial
        • Medical
        • Military
      • Cupron Technology
        • The Power of Copper
        • The Cupron Difference
        • Safety Testing
        • The Environment
        • Scientific Data
      • Manufacturing
        • Manufacturing Process
        • Different Substrates
    • The Power of Copper
    • The Cupron Difference
    •  Safety Testing
    • The Environment
    • Scientific Data
    • Follow Us

    • Home
    •  › 
    • Cupron Technology
    •  › 
    • Safety Testing

    Safety Testing

    Because Cupron Technology is based on copper oxide which is a natural, non-soluble form of copper, and copper is a required nutrient for healthier living, the body is generally capable of processing copper and maintaining proper copper levels.

     

    Cupron Technology has been multiple-independently tested in laboratory settings against generally accepted clinical test protocols, utilizing standard Good Laboratory Practices (GLP) test conditions. And under these conditions, Cupron Technology is consistently found to be non-toxic, non sensitizing, and non-irritating to the skin with no adverse events reported. Cupron Enhanced products tested include healthcare linens, socks, consumer bedding, wound dressing prototypes, and antiviral masks.  

    Specific test results are maintained on file and available upon a qualified request.

     

    In addition to specific safety testing performed on Cupron Technology, the risk of dermal sensitivity to copper is considered extremely minimal. Furthermore, longstanding commercial use of personal care products validates the laboratory results described above. That copper is considered safe to humans. Note the widespread (millions of women) and prolonged (more than 10 years by a single individual) use by women of copper internal medical devices (1) and over-the-counter wound healing  treatments containing copper (2).

     

     
    (1)Hubacher et al (2001) Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. N Engl J Med. 345:561-7; Anon. (2002) Copper IUDs, infection and infertility. Drug Ther Bull. 40:67-9; Bilian X. (2002) Intrauterine devices. Best Pract Res Clin Obstet Gynaecol. 16:155-68.

    (2)Pereira CE, and Felcman J. (1998) Correlation between five minerals and the healing effect of Brazilian medicinal plants. Biol Trace Elem Res. 65:251-259; Schlemm et al. (1999) Medicinal yeast extracts. Cell Stress Chaperones. 1999;4:171-6.

     

     

    •  
      • © Copyright Cupron 2008, All rights reserved.
        • Cupron
        •   |  
        • About Cupron
        •   |  
        • Markets
        •   |  
        • The Power of Copper
        •   |  
        • FAQ
        •   |  
        • Cupron Technology
        •   |  
        • Manufacturing

      • Product claims that can be made for products containing Cupron technology vary by country and by product. In particular, all antimicrobial claims in the US
        are strictly regulated by the US EPA, which allows only preservative "treated article" claims, while structure-function/disease-treatment claims in the US need
        to be pre-market approved by the US FDA. Partners and customers should consult Cupron for all questions regarding product claims in particular countries

    •